Centenial Surgical Suture Ltd. (BOM:531380)

India · Delayed Price · Currency is INR

78.31

+3.31 (4.41%)

At close: Jun 22, 2026

-45.99% (1Y)

Market Cap	285.70M -26.8%
Revenue (ttm)	538.40M +0.6%
Net Income	-22.05M
EPS	-6.04
Shares Out	3.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107
Open	76.30
Previous Close	75.00
Day's Range	76.30 - 78.70
52-Week Range	73.04 - 189.00
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About Centenial Surgical Suture

Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures, which include centibond, centiiwax, ... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 1995

Employees 280

Stock Exchange Bombay Stock Exchange

Ticker Symbol 531380

Full Company Profile

Financial Performance

In fiscal year 2026, Centenial Surgical Suture's revenue was 538.40 million, an increase of 0.61% compared to the previous year's 535.16 million. Losses were -22.05 million, 50.6% more than in 2025.

Financial Statements